ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,381Medicare Part D Prescriptions Filled, Including Refills

Rank: 247 out of 1942

$276K Total Retail Price of All Prescriptions

Rank: 556 out of 1942

380 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 380 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 380 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,576 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LEVOTHYROXINE SODIUM 416 409 1 3
FUROSEMIDE 381 356 2 5
LISINOPRIL 372 324 3 2
OMEPRAZOLE 246 220 4 4
HYDROCODONE-ACETAMINOPHEN 231 216 S3 5 12
SIMVASTATIN 221 177 6 1
CITALOPRAM HBR 220 220 7 15
METOPROLOL SUCCINATE 210 188 8 13
HYDROCHLOROTHIAZIDE 183 162 9 8
GABAPENTIN 173 164 10 16
SERTRALINE HCL 156 151 11 20
ATENOLOL 145 145 12 7
METOPROLOL TARTRATE 129 91 13 9
TRAMADOL HCL 114 97 14 19
MIRTAZAPINE 111 111 15 38
CYMBALTA 95 86 16 62
NAMENDA 92 92 17 51
POLYETHYLENE GLYCOL 3350 92 88 17 28
AMLODIPINE BESYLATE 89 79 19 6
ALLOPURINOL 82 76 20 26
WARFARIN SODIUM 80 67 21 11
GENERLAC 74 74 22 227
TAMSULOSIN HCL 71 71 23 29
CARBIDOPA-LEVODOPA 67 67 24 64
QUETIAPINE FUMARATE 66 66 25 61
POTASSIUM CHLORIDE 61 61 26 17
OXYCODONE HCL 61 43 S2 26 52
DONEPEZIL HCL 61 61 26 30
LANSOPRAZOLE 58 55 29 125
KLOR-CON M20 58 57 29 97
MORPHINE SULFATE ER 53 51 S2 31 88
SPIRIVA 53 42 31 57
METFORMIN HCL 52 36 33 10
JANTOVEN 52 52 33 33
CHLORTHALIDONE 51 51 35 76
GLIMEPIRIDE 50 49 36 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.